United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 7 minute read Pharma Industry News Entropy Neurodynamics (ASX: ENP) hits TRP-8803 trial milestone as IV psilocin approach draws patient momentum Entropy Neurodynamics (ASX: ENP) completes Cohort 1 recruitment for its TRP-8803 IV psilocin BED trial. Here's what the milestone means for investors. Read more. bySrinathMarch 3, 2026